The Vanguard Group 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:16 pm Sale |
2023-12-29 | 13G | Vanda Pharmaceuticals Inc. VNDA |
The Vanguard Group | 3,456,087 6.010% |
-536,079 (-13.43%) |
Filing |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Vanda Pharmaceuticals Inc. VNDA |
The Vanguard Group | 3,992,166 7.050% |
115,482 (+2.98%) |
Filing |
| 2022-02-10 08:42 am Sale |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
The Vanguard Group | 3,876,684 6.960% |
-82,396 (-2.08%) |
Filing |
| 2021-02-10 11:57 am Sale |
2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
The Vanguard Group | 3,959,080 7.240% |
-501,703 (-11.25%) |
Filing |